少用量水化物抑制剤の世界市場:産業分析・市場機会

【英語タイトル】Low dosage Hydrate Inhibitors Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028

Future Market Insightsが出版した調査資料(FUMI906082)・商品コード:FUMI906082
・発行会社(調査会社):Future Market Insights
・発行日:2019年4月
・ページ数:243
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:化学・材料
◆販売価格オプション(消費税別)
Individual Price(1名様閲覧用)USD5,000 ⇒換算¥535,000見積依頼/購入/質問フォーム
Corporate Price(同一法人内共有可)USD7,500 ⇒換算¥802,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートでは、少用量水化物抑制剤の世界市場について調査・分析し、以下の構成でお届けいたします。
・少用量水化物抑制剤の世界市場の世界市場概観
・少用量水化物抑制剤の世界市場の世界市場規模
・少用量水化物抑制剤の世界市場の世界市場予測
・少用量水化物抑制剤の世界市場の世界市場:地域別市場分析
・少用量水化物抑制剤の世界市場のアメリカ市場規模
・少用量水化物抑制剤の世界市場のヨーロッパ市場規模
・少用量水化物抑制剤の世界市場のアジア市場規模
・少用量水化物抑制剤の世界市場の世界市場:製品別(抗凝集剤(AA)阻害剤、キネティック水和物阻害剤)
・少用量水化物抑制剤の世界市場の世界市場:競争状況
・少用量水化物抑制剤の世界市場の世界市場:市場動向
・少用量水化物抑制剤の世界市場の世界市場:関連企業分析
【レポートの概要】

Market Introduction

Hydrate inhibitors are used in order to prevent the formation of gas hydrates at lower temperature and high pressure conditions. There are two types of hydrate inhibitors – thermodynamic inhibitors and low dosage hydrate inhibitors. Low dosage hydrate inhibitors are chemicals that help manage flow without the huge volume of chemicals that are required for thermodynamic inhibition. These are cost-effective chemicals and easy to use.

The primary advantages of low dosage hydrate inhibitors are that they require lower transportation costs, lower storage costs, and less maintenance; are effective during extended shut-ins; etc. Low dosage hydrate inhibitors are of two types – anti-agglomerate (AA) inhibitors and kinetic hydrate inhibitors (KHIs). They are mainly utilized in onshore and offshore operations in the oil and gas industry.

The report on the global low dosage hydrate inhibitors market studied the market for the next ten years, i.e. 2018-2028. The report has market values in 000’ US$ and market volumes in tons, and we have considered 2017 as the base year for the low dosage hydrate inhibitors market.

The report on the global low dosage hydrate inhibitors market has numerous sections that describe the entire scope of study, segment-wise. Initially, in the first section of the report, we have provided the executive summary of the global low dosage hydrate inhibitors market. In that, we have offered the outlook of the global low dosage hydrate inhibitors market

In the second section of the global low dosage hydrate inhibitors market report, we offer the market overview, market definition, and market taxonomy. In the next section, the report has key trends and Porter’s analysis of the global low dosage hydrate inhibitors market.

Next section of the global low dosage hydrate inhibitors market report has the entire outlook of the market background. Under this, we have included GDP outlook by region, offshore rigs by region, oil and gas production outlook, natural gas demand, natural gas production outlook, global energy consumption overview, chemical industry outlook, and patent analysis of the low dosage hydrate inhibitors market.

In the next section of the global low dosage hydrate inhibitors market, value chain analysis has been included along with a list of the distributors and manufactures of low dosage hydrate inhibitors. The global low dosage hydrate inhibitors market report has forecast factors, drivers, restrains, trends, and opportunity analysis for low dosage hydrate inhibitor manufactures. The next section of the report includes the pricing analysis by region, global value (000’ US$) and global volume (tons) analysis for the historical as well as the forecasted years. In the following section of the report, the value and volume analysis by segment (by product type, by terrain type, and by country) has been described for all regions – North America, Latin America, Europe, South East, East Asia, Oceania, and the Middle East & Africa.

The next section of the report includes the emerging market analysis, and comparison analysis of emerging and global markets by value and volume. PEST analysis for emerging economies has been included under this section. In the final section of the global low dosage hydrate inhibitors market report, we have included the competition benchmark, market analysis by tier, market concentration, competition dashboard, and company profiles of low dosage hydrate inhibitors.

In the competition analysis section, the report highlights some of the top companies operating in the global low dosage hydrate inhibitors market, such as BASF SE, Schlumberger Limited, Arkema Group, Baker Hughes Incorporated (BGHE), Clariant AG, Ecolab Inc., Evonik Industries AG, Force Chem Technologies LLC, Halliburton Co., and Gas Hydrate LLC, among others.

Research Methodology

Market volume for low dosage hydrate inhibitors are inferred through in-depth secondary research and validated from primary resources or interviews We have collected the data from private as well as public sources, such as – annual reports, newsletter, magazines, research papers, Factiva, BVD (Bureau van Dijk), etc. The price for low dosage hydrate inhibitors is analyzed on the basis of product type – anti-agglomerate and kinetic hydrate inhibitors (KHI), which is inferred across the all seven regions. The global value of the low dosage hydrate inhibitors market is thus calculated from the data gathered from secondary as well as primary resources, utilizing average price and market volume

For the next 10 years forecast of the low dosage hydrate inhibitors market, various market viewpoints, macroeconomic factors, and challenging trends are observed. For forecasting the market, we have considered both, supply-side trends and demand-side trends, and other dynamics that have an impact on the low dosage hydrate inhibitors market.

Forecast has been conducted in term of CAGR, Y-O-Y growth, and absolute dollar opportunity, presenting the client with crystal clear insights and future opportunities as far as the low dosage hydrate inhibitors market is concerned.

【レポートの目次】

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Technology Roadmap

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Taxonomy

2.2. Market Definition

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Development Trends

3.3. Porter’s Analysis

4. Key Success Factors

4.1. Product Adoption Rate

4.2. Technology Adoption Rate

4.3. Strategic Promotional Strategies

5. Market Background

5.1. Macro-Economic Factors

5.1.1. Global GDP Growth Outlook

5.1.2. Global Offshore Rigs By Region

5.1.3. Global Oil & Gas Production Forecast Outlook

5.1.4. Natural Gas Demand Forecast

5.1.5. Natural Gas Production By Region

5.1.6. Global Energy Consumption

5.1.7. Shale Gas Resources By country

5.1.8. Global Chemical Sales

5.1.9. Parent Market Outlook

5.1.10. Patent Analysis

5.2. Value Chain Analysis

5.2.1. List of Distributors

5.3. Forecast Factors – Relevance & Impact

5.4. Market Dynamics

5.4.1. Drivers

5.4.2. Restraints

5.4.3. Opportunity Analysis

6. Global Low Dosage Hydrate Inhibitors Market Demand Analysis 2013-2017 and Forecast, 2018-2028

6.1. Historical Market Volume (Tons) Analysis, 2013-2017

6.2. Current and Future Market Volume (Tons) Projections, 2018-2028

6.3. Y-o-Y Growth Trend Analysis

6.4. Pricing Analysis

6.5. Global Low Dosage Hydrate Inhibitors Market Demand (000’US$ ) Analysis 2013-2017 and Forecast, 2018-2028

7. Global Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028, by Product Type

7.1. Introduction / Key Findings

7.2. Historical Market Size (000’US$ ) and Volume Analysis By Product Type, 2013 – 2017

7.3. Current and Future Market Size (000’US$ ) and Volume Analysis and Forecast By Product Type, 2018 – 2028

7.3.1. Anti-Agglomerate (AA) inhibitors

7.3.2. Kinetic Hydrate Inhibitors (KHI)

7.4. Market Attractiveness Analysis By Product Type

8. Global Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028, by Terrain Type

8.1. Introduction / Key Findings

8.2. Historical Market Size (000’US$ ) and Volume Analysis By Terrain Type, 2013 – 2017

8.3. Current and Future Market Size (000’US$ ) and Volume Analysis and Forecast By Terrain Type, 2018 – 2028

8.3.1. Onshore

8.3.2. Offshore

8.4. Market Attractiveness Analysis By Terrain Type

9. Global Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028, by Region

9.1. Introduction

9.2. Historical Market Size (000’US$ ) and Volume Analysis By Region, 2013 – 2017

9.3. Current Market Size (000’US$ ) and Volume Analysis and Forecast By Region, 2018 – 2028

9.3.1. North America

9.3.2. Latin America

9.3.3. Europe

9.3.4. East Asia

9.3.5. South Asia

9.3.6. Oceania

9.3.7. Middle East and Africa (MEA)

9.4. Market Attractiveness Analysis By Region

10. North America Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028

10.1. Introduction

10.2. Pricing Analysis

10.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 – 2017

10.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2018 – 2028

10.4.1. By Country

10.4.1.1. U.S.

10.4.1.2. Canada

10.4.2. By Product Type

10.4.3. By Terrain Type

10.5. Market Attractiveness Analysis

10.5.1. By Country

10.5.2. By Product Type

10.5.3. By Terrain Type

10.6. Market Trends

10.7. Key Market Participants – Intensity Mapping

10.8. Drivers and Restraints – Impact Analysis

11. Latin America Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028

11.1. Introduction

11.2. Pricing Analysis

11.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 – 2017

11.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2018 – 2028

11.4.1. By Country

11.4.1.1. Brazil

11.4.1.2. Mexico

11.4.1.3. Rest of Latin America

11.4.2. By Product Type

11.4.3. By Terrain Type

11.5. Market Attractiveness Analysis

11.5.1. By Country

11.5.2. By Product Type

11.5.3. By Terrain Type

11.6. Market Trends

11.7. Key Market Participants – Intensity Mapping

11.8. Drivers and Restraints – Impact Analysis

12. Europe Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028

12.1. Introduction

12.2. Pricing Analysis

12.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 – 2017

12.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2018 – 2028

12.4.1. By Country

12.4.1.1. Germany

12.4.1.2. Italy

12.4.1.3. France

12.4.1.4. U.K.

12.4.1.5. Spain

12.4.1.6. BENELUX

12.4.1.7. Russia

12.4.1.8. Rest of Europe

12.4.2. By Product Type

12.4.3. By Terrain Type

12.5. Market Attractiveness Analysis

12.5.1. By Country

12.5.2. By Product Type

12.5.3. By Terrain Type

12.6. Market Trends

12.7. Key Market Participants – Intensity Mapping

12.8. Drivers and Restraints – Impact Analysis

13. South Asia Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028

13.1. Introduction

13.2. Pricing Analysis

13.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 – 2017

13.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2018 – 2028

13.4.1. By Country

13.4.1.1. India

13.4.1.2. Thailand

13.4.1.3. Indonesia

13.4.1.4. Malaysia

13.4.1.5. Rest of South Asia

13.4.2. By Product Type

13.4.3. By Terrain Type

13.5. Market Attractiveness Analysis

13.5.1. By Country

13.5.2. By Product Type

13.5.3. By Terrain Type

13.6. Market Trends

13.7. Key Market Participants – Intensity Mapping

13.8. Drivers and Restraints – Impact Analysis

14. East Asia Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028

14.1. Introduction

14.2. Pricing Analysis

14.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 – 2017

14.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2018 – 2028

14.4.1. By Country

14.4.1.1. China

14.4.1.2. Japan

14.4.1.3. South Korea

14.4.2. By Product Type

14.4.3. By Terrain Type

14.5. Market Attractiveness Analysis

14.5.1. By Country

14.5.2. By Product Type

14.5.3. By Terrain Type

14.6. Market Trends

14.7. Key Market Participants – Intensity Mapping

14.8. Drivers and Restraints – Impact Analysis

15. Oceania Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028

15.1. Introduction

15.2. Pricing Analysis

15.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 – 2017

15.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2018 – 2028

15.4.1. By Country

15.4.1.1. Australia

15.4.1.2. New Zealand

15.4.2. By Product Type

15.4.3. By Terrain Type

15.5. Market Attractiveness Analysis

15.5.1. By Country

15.5.2. By Product Type

15.5.3. By Terrain Type

15.6. Market Trends

15.7. Key Market Participants – Intensity Mapping

15.8. Drivers and Restraints – Impact Analysis

16. Middle East and Africa Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028

16.1. Introduction

16.2. Pricing Analysis

16.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 – 2017

16.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2018 – 2028

16.4.1. By Country

16.4.1.1. GCC Countries

16.4.1.2. Turkey

16.4.1.3. Northern Africa

16.4.1.4. South Africa

16.4.1.5. Rest of Middle East and Africa

16.4.2. By Product Type

16.4.3. By Terrain Type

16.5. Market Attractiveness Analysis

16.5.1. By Country

16.5.2. By Product Type

16.5.3. By Terrain Type

16.6. Market Trends

16.7. Key Market Participants – Intensity Mapping

16.8. Drivers and Restraints – Impact Analysis

17. Emerging Countries Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028

17.1. Introduction

17.1.1. Market Value Proportion Analysis, By Key Countries

17.1.2. Global Vs. Country Growth Comparison

17.2. Canada Low Dosage Hydrate Inhibitors Market Analysis

17.2.1. Introduction

17.2.2. Pricing Analysis

17.2.3. PEST Analysis

17.2.4. Market Value Proportion Analysis by Market Taxonomy

17.2.5. Market Volume (Tons) and Value (000’US$ ) Analysis and Forecast by Market Taxonomy

17.2.5.1. By Product Type

17.2.5.2. By Terrain Type

17.2.6. Canada Low Dosage Hydrate Inhibitors Market – Competition Landscape

17.2.7. Canada – Trade Analysis

17.3. The U.S. Low Dosage Hydrate Inhibitors Market Analysis

17.3.1. Introduction

17.3.2. Pricing Analysis

17.3.3. PEST Analysis

17.3.4. Market Value Proportion Analysis by Market Taxonomy

17.3.5. Market Volume (Tons) and Value (000’US$ ) Analysis and Forecast by Market Taxonomy

17.3.5.1. By Product Type

17.3.5.2. By Terrain Type

17.3.6. The U.S. Low Dosage Hydrate Inhibitors Market – Competition Landscap

17.4. Brazil Low Dosage Hydrate Inhibitors Market Analysis

17.4.1. Introduction

17.4.2. Pricing Analysis

17.4.3. PEST Analysis

17.4.4. Market Value Proportion Analysis by Market Taxonomy

17.4.5. Market Volume (Tons) and Value (000’US$ ) Analysis and Forecast by Market Taxonomy

17.4.5.1. By Product Type

17.4.5.2. By Terrain Type

17.4.6. Brazil Low Dosage Hydrate Inhibitors Market – Competition Landscape

18. Market Structure Analysis

18.1. Market Analysis by Tier of Companies (Low Dosage Hydrate Inhibitors)

18.2. Market Concentration

18.3. Market Share Analysis of Top Players

18.4. Market Presence Analysis

18.4.1. By Regional footprint of Players

18.4.2. Product foot print by Players

18.4.3. Channel Foot Print by Players

19. Competition Analysis

19.1. Competition Dashboard

19.2. Pricing Analysis by Competition

19.3. Competition Benchmarking

19.4. Competition Deep Dive

19.4.1. BASF SE

19.4.1.1. Overview

19.4.1.2. Product Portfolio

19.4.1.3. Profitability by Market Segments (Product/Channel/Region)

19.4.1.4. Sales Footprint

19.4.1.5. Strategy Overview

19.4.1.5.1. Marketing Strategy

19.4.1.5.2. Product Strategy

19.4.1.5.3. Channel Strategy

19.4.2. Schlumberger

19.4.3. Arkema Group

19.4.4. Ashland

19.4.5. ERO CHEM LLC

19.4.6. Halliburton

19.4.7. Baker Hughes Incorporated

19.4.8. Clariant Chemicals

19.4.9. Ecolab

19.4.10. GasHydrate LLC

20. Assumptions and Acronyms Used

21. Research Methodology



★調査レポート[少用量水化物抑制剤の世界市場:産業分析・市場機会] (コード:FUMI906082)販売に関する免責事項を必ずご確認ください。
★調査レポート[少用量水化物抑制剤の世界市場:産業分析・市場機会]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆